Background: There is growing evidence that genetic variants have an impact on the pathogenesis of intracranial aneurysm (IA). Recently, the genetic locus around the elastin gene (7q11) has been identified as linked to IA in a Japanese population. Our aim was to confirm these results in Caucasian populations. Methods: We conducted a case-control study in 120 Caucasian patients with IA and 172 controls to investigate 8 single nucleotide polymorphisms (SNPs) and various haplotypes within the elastin gene, which were frequently found and associated with the phenotype in the Japanese populations. Real-time PCR and melting curve analysis were used for the detection of genotypes. Results: Allele frequencies and genotypes were equally distributed between Caucasian cases and controls. We failed to identify haplotypes that are associated with the phenotype in our population, which is in contrast to the Japanese study. However, allele frequencies in control populations differ between Caucasians and Japanese. Conclusions: We found no association between SNPs and haplotypes of the elastin gene and the occurrence of IA in our Caucasian populations. However, our data provide strong evidence for racial/ethnic differences in the association of SNP and specific haplotypes of the elastin gene with the phenotype. There might be other genetic variants of the elastin gene associated with IA in Caucasians. / Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.

Background: Vascular remodeling generated by reactive oxygen species contributes to aneurysm formation. The NADPH oxidase system is a major source of superoxide anion not only in phagocytes, but also in endothelial and vascular smooth muscle cells. Polymorphisms of p22phox, an essential component of the NADPH oxidase system, are found to be associated with atherosclerosis, while a recent study found a significant association between the 214C>T polymorphism and the occurrence of ischemic cerebrovascular disease. We conducted a case-control study to investigate the relationship of five polymorphisms of the p22phox gene and the occurrence of cerebral aneurysms. Methods: The study population consisted of 113 patients with intracranial aneurysms and 53 control subjects. The 214C>T polymorphism was investigated by restriction fragment length polymorphism analysis, while polymorphisms 381T>C, 480G>A, 521C>T, and *24A>G were analyzed by direct sequencing of exon 6 and adjacent intronic sequences. Results: The analysis of a primary study sample comprising 35 cases and 28 controls failed to show a significant association between any of the five polymorphisms and the occurrence of intracranial aneurysms using both allele frequencies and genotypes (all nominal p > 0.05). Although there was a deviation from Hardy-Weinberg equilibrium in cases at the 521C>T locus (nominal p < 0.05), this could not be confirmed in a second study sample of 78 patients. Haplotypes were constructed regarding three frequent polymorphisms (214C>T, 521C>T, and *24A>G); haplotype frequencies in cases and controls were not significantly different. Conclusion: Although polymorphisms of the p22phox gene located in the coding region and the 3′-untranslated region were reported to be associated with atherosclerosis and cerebrovascular disease, our data provide evidence that there is no association between these polymorphisms and the occurrence of cerebral aneurysms in Caucasians. / Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.

Introduction: Idiopathic dilatation of the right atrium (IDRA) is a rare abnormality usually detected by chance at any time between antenatal and adult life. It is defined as isolated enlargement of the right atrium in the absence of other cardiac lesions causing right atrial dilatation. IDRA can be associated with atrial arrhythmia and systemic embolism. The clinical presentation shows high variability ranging from the lack of any symptoms up to cardiac failure. Methods/Results: We describe 2 children with antenatally diagnosed IDRA, the intrauterine course in 1 case, the postnatal management and its long-term follow-up. There has been no need for surgical intervention so far because of the lack of arrhythmias and no further progression of right atrial diameters. Thrombus formation in the right atrium, which is a potential risk for pulmonary embolism, led us to initiate anticoagulation in our cases to prevent such complications. Furthermore, we suggest one possible pathomechanism of congenital right atrial dilatation. Conclusion: Optimal management of severe IDRA depends on the individual case. Long-term follow-up of these patients is necessary to monitor a possible further progression of right atrial size and occurrence of arrhythmias. As a possible pathomechanism, a functional partial anomalous pulmonary venous insertion may imitate a structural abnormal pulmonary vein connection in some idiopathic cases of congenital right atrial dilatation. / Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.

Bakgrund Bukaortaaneurysm är en potentiell farlig sjukdom med en dödlighet på 80-90% vid bristning. I Sverige screenas således alla 65-åriga män med ultraljud för att upptäcka aneurysmen i tid innan den brister och erbjuda männen behandling.  Syfte Syftet med examensarbetet var att utvärdera den interindividuella mätosäkerheten hos legitimerade och erfarna biomedicinska analytiker vid screening av bukaorta med ultraljud på 65-åriga män.  Material och metod Den interindividuella mätosäkerheten har utvärderats hos två par erfarna biomedicinska analytiker (BMA). BMA-paren screenade och registrerade bukaortandiametern på 65-åriga män vid två olika fysiologiska kliniker med metoden leading edge to leading edge (LELE) i anteroposteiror riktning. Analysen av data har genomförts med programmet IBM SPSS Statistics.  Resultat Analysen av data visade ingen signifikant skillnad i mätosäkerhet mellan BMA eller mellan klinikerna. Skillnaden i medelvärde mellan BMA låg på -0,06 mm respektive -0,07 mm. Medianen för skillnaderna av mätresultaten för respektive BMA-par var 0,0 mm (-0,5 til 0,4 mm, 95% CI) och -0,3 mm (-0,6 till 0,5 mm, 95% CI). Mätosäkerheten påverkades inte av BMI.  Slutsatser Utbildade och erfarna BMA som följer samma undersökningsprotokoll uppnår en hög nivå av interindividuell mätsäkerhet vid screening av bukaortaaneurysm med ultraljud.  Nyckelord: Bukarotaaneurysm, biomedicinska analytiker, interindividuell variation, LELE

BACKGROUND: Posterior inferior cerebellar artery (PICA) aneurysms are an uncommon, heterogeneous group of aneurysms with poorer neurological outcomes compared to other intracranial aneurysms. At first, as part A, we conducted a systematic review of the literature to evaluate the safety and efficacy of treatment strategies for PICA-aneurysms. Subsequently, as part B, we performed a multicenter retrospective study to analyze the outcome in a large series of patients treated with contemporary microsurgical and endovascular techniques. METHODS: For the meta-analysis, a systematic search of Medline, EMBASE, Scopus and Web of Science was done for studies published through November 2015. We included studies that described treatment of PICA-aneurysms with ≥10 patients. Random-effects meta-analysis was used to pool the following outcomes: complete occlusion, technical success, periprocedural morbidity/mortality, stroke rates, aneurysm recurrence/rebleed, CN-palsies rates, and long-term neurological morbidity/mortality. As the second part, aiming to report the current trends and results in treatment strategies for PICA-aneurysms, records of 94 patients treated for PICA-aneurysms between 2000 and 2015 at 3 large referral neurovascular centers were retrospectively reviewed. RESULTS: In the meta-analysis, we...

Background: The ideal treatment strategy for patients with cryptogenic stroke and patent foramen ovale (PFO) is not yet clear. Previous randomized controlled trials (RCTs) comparing transcatheter PFO closure with medical therapy in patients with cryptogenic stroke to prevent recurrent ischemic stroke showed mixed results. This meta-analysis aims to compare rates of recurrent stroke, transient ischemic attack (TIA) and all-cause mortality with PFO closure and medical therapy vs. medical therapy alone. Methods: PubMed and the Cochrane Center Register of Controlled Trials were searched for studies published through June 2018, comparing PFO closure plus medical therapy versus medical therapy alone. Six RCTs (n = 3750) comparing PFO closure with medical therapy were included in the analysis. End points were recurrent stroke, TIA and all-cause mortality. The odds ratios (OR) with 95% confidence interval (CI) were computed and p < 0.05 was considered as a level of significance. Results: A total of 1889 patients were assigned to PFO closure plus medical therapy and 1861 patients were assigned to medical therapy only. Risk of recurrent stroke was significantly lower in the PFO closure plus medical therapy group compared to medical therapy alone. (OR 0.47, 95% CI 0.33–0.67, p < 0.0001). Rate of TIA was similar between the two groups (OR 0.76, 95% CI 0.52–1.14), p = 0.18). There was no difference in all-cause mortality between two groups (OR 0.73, CI 0.33–1.58, p = 0.42). Patients undergoing PFO closure were more likely to develop transient atrial fibrillation than medical therapy alone (OR: 5.85; CI: 3.06–11.18, p ≤0.0001) whereas the risk of bleeding was similar between the groups (OR: 0.93; CI: 0.55–1.57, p = 0.78). Conclusions: The results of this meta-analysis suggest that transcatheter closure of PFO plus medical therapy is superior to medical therapy alone for the prevention of recurrent cryptogenic stroke. However, PFO closure in these patients has not been shown to reduce the risk of recurrent TIA or all-cause mortality. There is a higher rate of transient atrial fibrillation post PFO closure device placement, the long-term effects of which have yet to be studied.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第20983号 / 医博第4329号 / 新制||医||1027(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 竹内 理, 教授 杉田 昌彦, 教授 湊谷 謙司 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

New technologies have greatly shaped the scientific and medical landscape within the last years. The unprecedented expansion of data and information on RNA biology has led to the discovery of new RNA classes with unique functions and unexpected modifications. Today, the biggest challenge is to transfer the large number of findings in basic RNA biology into corresponding clinical RNA-based therapeutics. Lately, this research begins to yield positive outcomes. RNA drugs advance to the final phases of clinical trials or even receive FDA approval. Furthermore, the introduction of the RNA-guided gene-editing technology CRISPR and advances in the delivery ofmessenger RNAs have triggered a major progression in the field of RNA-therapeutics. Especially short interfering RNAs and antisense oligonucleotides are promising examples for novel categories of therapeutics. However, several issues need to be addressed including intracellular delivery, toxicity, and immune responses before utilizing RNAs in a clinical setting. In this review, we provide an overview on opportunities and challenges for clinical translation of RNA-based therapeutics, with an emphasis on advances in novel delivery technologies and abdominal aortic aneurysm disease where non-coding RNAs have been shown to play a crucial regulatory role.

The hidden Markov model (HMM) is one of the workhorse tools in, for example, statistical signal processing and machine learning. It has found applications in a vast number of fields, ranging all the way from bioscience to speech recognition to modeling of user interactions in social networks. In an HMM, a latent state transitions according to Markovian dynamics. The state is only observed indirectly via a noisy sensor – that is, it is hidden. This type of model is at the center of this thesis, which in turn touches upon three main themes. Firstly, we consider how the parameters of an HMM can be estimated from data. In particular, we explore how recently proposed methods of moments can be combined with more standard maximum likelihood (ML) estimation procedures. The motivation for this is that, albeit the ML estimate possesses many attractive statistical properties, many ML schemes have to rely on local-search procedures in practice, which are only guaranteed to converge to local stationary points in the likelihood surface – potentially inhibiting them from reaching the ML estimate. By combining the two types of algorithms, the goal is to obtain the benefits of both approaches: the consistency and low computational complexity of the former, and the high statistical efficiency of the latter. The filtering problem – estimating the hidden state of the system from observations – is of fundamental importance in many applications. As a second theme, we consider inverse filtering problems for HMMs. In these problems, the setup is reversed; what information about an HMM-filtering system is exposed by its state estimates? We show that it is possible to reconstruct the specifications of the sensor, as well as the observations that were made, from the filtering system’s posterior distributions of the latent state. This can be seen as a way of reverse engineering such a system, or as using an alternative data source to build a model. Thirdly, we consider Markov decision processes (MDPs) – systems with Markovian dynamics where the parameters can be influenced by the choice of a control input. In particular, we show how it is possible to incorporate prior information regarding monotonic structure of the optimal decision policy so as to accelerate its computation. Subsequently, we consider a real-world application by investigating how these models can be used to model the treatment of abdominal aortic aneurysms (AAAs). Our findings are that the structural properties of the optimal treatment policy are different than those used in clinical practice – in particular, that younger patients could benefit from earlier surgery. This indicates an opportunity for improved care of patients with AAAs. / <p>QC 20180301</p>

Historique et Objectif : La littérature est conflictuelle sur le rôle des calcifications aortiques dans la rupture d’anévrisme de l’aorte abdominale (AAA). La prédiction de rupture d’AAA basée sur le sexe et le diamètre est peu précise. Le but de ce projet était donc de déterminer si les calcifications permettent de mieux prédire la rupture d’AAA que le sexe et le diamètre à eux seuls. Méthodologie : Lors de cette étude rétrospective, 80 patients traités pour rupture d’AAA entre Janvier 2001 et Août 2018 ont été appariés à 80 patients non-rompus sur la base du diamètre maximal d’AAA, de l’âge, du sexe et de la présence de contraste lors du scan. La charge et la répartition des calcifications de la paroi aortique ainsi que certaines variables morphologiques d’anévrisme ont été comparées entre les deux groupes par analyse univariée et apprentissage machine. Résultats : L’âge moyen des patients était de 74.0 ± 8.4 ans et 89% étaient des hommes. Les diamètres d’AAA étaient équivalents entre groupes (80.9 ± 17.5 vs 79.0 ± 17.3 mm, p= 0.505). Selon l’analyse univariée, les anévrismes rompus comportaient significativement moins d’agrégats de calcifications (18.0 ± 17.9 vs 25.6 ± 18.9, p=0.010) et étaient moins enclins à avoir un collet (45.0% vs 76.3%, p<0.0001). Les 5 variables les plus importantes délivrées par l’apprentissage machine étaient: collet, antiplaquettaires, nombre de calcifications, distance d’Euler entre calcifications et finalement l’écart-type de la distance d’Euler entre calcifications. Le modèle à 5 variables a produit une aire sous la courbe (AUC) de 0.81 ± 0.02 (sensibilité 83% et spécificité 71%), supérieure à une AUC de 0.67(IC 95%, 0.58-0.77%) (sensibilité 60% et spécificité 77%) obtenues dans une étude antérieure avec une population similaire à celle-ci et ne tenant compte que du sexe et du diamètre. Conclusion : La charge en calcifications des anévrismes rompus était moins bien répartie que celle des non-rompus. Le modèle d’apprentissage machine a mieux prédit la rupture que le modèle basé uniquement sur le diamètre et le sexe. / Background and Purpose: Literature is conflictual regarding the role of aortic calcification in AAA rupture. AAA rupture prediction based on sex and diameter could be improved. The goal of this project was to assess whether aortic calcification could better predict AAA rupture. Methods: In this retrospective study, 80 patients treated for a ruptured AAA between January 2001 and August 2018 were matched with 80 non-ruptured patients based on maximal AAA diameter, age, sex and contrast enhancement status of the CT scan. Calcification load and dispersion, morphologic and clinical variables were compared between both groups using a univariable analysis and machine learning. Results: Mean age of patients was 74.0 ± 8.4 years and 89% were men. AAA diameters were equivalent in both groups (80.9 ± 17.5 vs 79.0 ± 17.3 mm, p= 0.505). Ruptured aneurysms contained a smaller number of calcification chunks than the non-ruptured (18.0 ± 17.9 vs 25.6 ± 18.9, p=0.010) and were less likely to have a proximal neck than the non-ruptured (45.0% vs 76.3%, p<0.0001). In the machine learning analysis, 5 variables were associated to AAA rupture: proximal neck, antiplatelets, calcification number, Euler distance between calcifications and standard deviation of the Euler distance between calcifications. The model including these 5 variables yielded an area under the curve (AUC) of 0.81 ± 0.02 (83% sensitivity and 71% specificity) which was better than a previous study with a similar population reporting a 0.67 AUC (95% CI, 0.58-0.77%) (60% sensitivity and 77% specificity) for sex and diameter only. Conclusion: Ruptured aneurysms were more likely to have their calcification load concentrated in a small number of clusters closer to each other. Our 5-variable model predicted rupture better than the model based on age and sex.